Article
TP53 mutation in prostate needle biopsies--comparison with patients follow-up.
Anticancer research - 1 Jan 2000
Ecke Thorsten H, Schlechte Horst H, Hübsch Anne, Lenk Severin V, Schiemenz Katrin, Rudolph Birgit D, Miller Kurt
Abstract excerpt
BACKGROUND: The predictive value of TP53 mutations and prostate-specific antigen (PSA) was assessed in prostate needle biopsies of samples without signs of malignancy for later affliction by prostate cancer (PCa). Comparison of mutation frequency and PSA level in prostate needle biopsies with data of patients with benign prostate hyperplasia (BPH) treated by transurethral resection (TURP), patients with prostatic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
